The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy

Renal Failure

Volumn 26, Issue 4, 2004, Pages 445-451

  Rocha, Keyla B F ^a   Soares, Vitor A ^a   Viero, Rosa M ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chronic renal failure; Interstitial fibrosis; Membranous glomerulonephritis; Myofibroblasts

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MORPHOMETRICS; MYOFIBROBLAST; NEPHROTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; FIBROSIS; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; MALE; MIDDLE AGED; MYOBLASTS; RETROSPECTIVE STUDIES;

EID: 4444254412     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200026764     Document Type: Article

References (30)

1. Donadio, J.V., Jr.; Torres, V.E.; Velosa, J.À.; Wagoner, R.D.; Holley, K.E.; Okamura, M.; Ilstrup, D.M.; Chu, C.P. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 1988, 33, 708-715.
2. Ramzy, M.H.; Cameron, J.S.; Turner, D.R.; Neild, G.H.; Ogg, C.S.; Hicks, L. The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 1981, 16, 13-19.
3. Sampaio, M.; Balbi, A.L.; Martin, L.C.; Chiou, C.S.; Cheide, L.; Pereira, A.C.C.; Bignardi, J.H.; Viero, R.M.; Soares, V.A. Glomerulonefrite membranosa idiopática: história natural e fatores prognósticos. Nephrologia Latino Americana 1995, 2, 175-183.
4. Bohle, A.; Wehrmann, M.; Bogenschütz, O.; Batz, C.; Vogl, W.; Schmitt, H.; Müller, C.A.; Müller, G.A. The long-term prognosis of the primary glomerulonephritis. A morphological and clinical analysis of 1747 cases. Pathol Res Pract 1992, 188, 908-924.
5. Ponticelli, C. Prognosis and treatment of membranous nephropathy. Kidney Int 1986, 29, 927-940.
6. Roberts, I.S.D.; Burrows, C.; Shanks, J.H.; Venning, M.; McWilliam, L.J. Interstitial myofibroblasts: predictors of prognosis in membranous nephropathy, J Clin Pathol 1997, 50, 123-127.
7. Wakai, S.; Magil, A.B. Focal glomerulosclerosis in idiopathic membranous nephropathy. Kidney Int 1992, 41, 428-434.
8. Bohle, A.; Mackensen-Haen, S.; Von Gise, H.; Grund, K.E.; Wehrmann, M.; Batz, C.H.; Bogenschütz, O.; Schmitt, H.; Nagy, Y.; Müller, C.; Müller, G. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990, 186, 135-144.
9. Row, P.G.; Cameron, J.S.; Turner, D.R.; Evans, D.J.; White, R.H.R.; OGG, C.S.; Chantler, C.; Brown, C.B. Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med 1975, 174, 207-239.
10. Tamimi, N.A.; Stevens, P.E.; O'Donnell, P.L.; Strange, P.G.; Muchaneta-Kubara, E.C.; El Nahas, A.M. Expression of cytoskeletal proteins differentiates between progressors and non-progressors in treated idiopathic membranous nephropathy. Exp Nephrol 1998, 6, 217-225.
11. Wehrmann, A.; Bohle, A.; Bogenschutz, O.; Eissele, R.; Freislederer, A.; Ohlschle, G.E.L.C.; Schumm, G.; Batz, C.; Gartner, H.U. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989, 31, 67-76.
12. Magil, A.B. Tubulointerstitial lesions in human membranous glomerulonephritis: relationship to proteinuria. Am J Kidney Dis 1995, 25 (3), 375-379.
13. Shearman, J.D.; Yin, Z.G.; Aarons, I.; Smith, P.S.; Woodroffe, A.J.; Clarkson, A.R. The effect of treatment with prednisolone or cyclophosphamide- warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. Clin Nephrol 1988, 30, 320-329.
14. Wang, H.; Tomino, Y.; Fukui, M.; Shirato, I.; Yaguchi, Y.; Ebihara, I.; Kubota, M.; Nakayama, S.; Koide, H. Correlation between tubulo-interstitial changes and prognosis in patients with primary membranous nephropathy. Nephron 1994, 67, 362 (letter).
15. Müller, G.A.; Markovic-Lipkovski, J.; Rodemann, H.P. The progression of renal diseases: on the pathogenesis of renal interstitial fibrosis. Klin Wochenschr 1991, 69, 576-586.
16. Alpers, C.E.; Hudkins, K.L.; Floege, J.; Johnson, R.J. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic injury. J Am Soc Nephrol 1994, 5, 201-210.
17. Goumenos, D.S.; Brown, C.B.; Shortland, J.; El Nahas, A.M. Myofibroblasts, predictors of progression of mesangial IgA Nephropathy? Nephrol Dial Transplant 1994, 9, 1418-1425.
18. Goumenos, D.; Tsomi, K.; Iatrou, C.; Oldroyd, S.; Sungur, A.; Papaioannides, D.; Moustakas, G.; Ziroyannis, P.; Mountokalakis, T.; El Nahas, A.M. Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 1998, 13, 1652-1661.
19. Groma, V.; Marcussen, N.; Olsen, S. A quantitative immunohistochemical study of the expression of mesangial α-smooth muscle actin and the proliferation marker KI-67 in glomerulonephritis in man. Virchows Arch 1997. 431, 345-350.
20. Sappino, A.P.; Schurch, W.; Gabbiani, G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotype modulations. Lab Invest 1990, 63, 144-161.
21. Johnson, R.J.; Floege, J.; Yoshimura, A.; Lida, H.; Couser, W.G.; Alpers, C.E. The activated mesangial cell: an activated myofibroblast? J Soc Nephrol 1992, 2, 190-197.
22. Yee-Yung, N.G.; Tung-Po, H.; Wu-Chang, Y.; Zheng-Ping, C.; An-Hang, Y.; Wei, M.U.; Nikoli, C.; Paterson, D.J.; Atkins, R.C.; Hui, Y.L. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulo-interstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998, 54, 864-876.
23. Zhang, G.; Moorhead, P.J.; El Nahas, A.M. Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995, 3, 308-318.
24. Hewitson, T.D.; Becker, G.L. Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995, 15, 111-117.
25. Badid, C.; Desmoulière, A.; McGregor, B.; Costa, A.M.A.; Fouque, D.; Hadjaissa, A.; Laville, M. Interstitial α-smooth muscle actin: a prognostic marker in membranous nephropathy. Clin Nephrol 1999, 52, 210-217.
26. Skalli, O.; Schurch, W.; Seemayer, T.; Lagace, R.; Montandon, D.; Pittet, B.; Gabbiani, G. Myofibroblast from diverse pathological settings are heterogeneous in their content of actin isoforms and intermediate filament protein. Lab Invest 1989, 60, 275-285.
27. Nöel, L.H.; Zanetti, M.; Droz, D.; Barbanel, C. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 1979, 66, 82-90.
28. Riemenschneider, T.; Mackensen-Haen, S.; Christ, H.; Bohle, A. Correlation between endogenous creatinine clearance and relative interstitial volume of the renal cortex in patients with diffuse membranous glomerulonephritis having a normal serum creatinine concentration. Lab Invest 1980, 43, 145-149.
29. Beregi, E.; Varga, I. Analysis of 260 cases of membranous glomerulonephritis in renal biopsy material. Clin Nephrol 1974, 2, 215-221.
30. Tu, W.H.; Petitti, D.B.; Biava, C.G.; Tulunay, O.; Hopper, J., Jr. Membranous nephropathy: predictors of terminal renal failure. Nephron 1984, 36, 118-124.